00524nas a2200157   4500000000100000000000100001008004100002100001100043700001200054700001500066700001800081700001500099245023200114490000600346022001400352       2012                            d1 aS. Lee1 aB. Monz1 aA. Clemens1 aM. Brueckmann1 aG . Y. Lip00aRepresentativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database0 v2  a2044-6055